ArticleCMI communications2026
AdMiRE study: Development and validation of a WHO-aligned tool to assess healthcare access and antibiotic use among migrant populations in Europe-a multicountry Delphi and psychometric study on behalf of ESGITM group.
Article in CMI communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Migrants and refugees face a high burden of infections caused by multidrug-resistant bacteria but frequently encounter structural barriers to healthcare and appropriate antibiotic treatment. This multicountry study applied a structured Delphi process to develop a standardized survey that systematically assesses healthcare access and barriers to appropriate antibiotic use among migrant and refugee populations in Europe. Methods: A multicountry Delphi consensus study was conducted with two different panels of experts including 64 experts from 12 European countries, from academia, clinical practice, nongovernmental organization, and migrant communities, to design and validate a survey on healthcare access and antibiotic use. Content validity was assessed using Item- and Scale-level Content Validity Indices (I-CVI and S-CVI/Ave) and the interquartile range. The finalized questionnaire was pilot-tested among 183 migrants, evaluating internal consistency (Cronbach's α; KR-20), temporal stability (intraclass correlation coefficient), inter-rater reliability (κ), and construct validity via exploratory factor analysis. Results: Fifteen of 16 experts (94%) completed both Delphi rounds. The S-CVI/Ave improved from 0.94 to 0.95, and the mean interquartile range decreased from 0.38 to 0.02, indicating strengthened content validity and consensus. External validation confirmed excellent agreement (S-CVI/Ave = 0.96). Psychometric testing demonstrated good reliability (Cronbach's α = 0.82-0.91; KR-20 = 0.79), substantial inter-rater agreement (κ = 0.72), and robust construct validity (KMO = 0.84; Bartlett's test p <0.001). Conclusions: The AdMiRE questionnaire is a reliable and methodologically robust tool for assessing healthcare access and antibiotic use among migrants and refugees in Europe. This validated instrument provides a standardized framework for generating comparable data to inform policies, strengthen antimicrobial stewardship, and promote equitable access to care across migrants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.